| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |